-
1
-
-
33644842108
-
Dipeptidyl peptidase IV inhibitors: A promising new therapeutic approach for the management of type 2 diabetes
-
DOI 10.1016/j.biocel.2005.09.011, PII S1357272505002955, Diabetes: New Research and Novel Therapies
-
Deacon, C. F.; Holst, J. J. Int. J. Biochem. Cell Biol. 2006, 38, 831-844. doi:10.1016/j.biocel.2005.09.011 (Pubitemid 43363415)
-
(2006)
International Journal of Biochemistry and Cell Biology
, vol.38
, Issue.5-6
, pp. 831-844
-
-
Deacon, C.F.1
Holst, J.J.2
-
3
-
-
33644834521
-
Applications of dipeptidyl peptidase IV inhibitors in diabetes mellitus
-
DOI 10.1016/j.biocel.2005.12.013, PII S1357272505004188, Diabetes: New Research and Novel Therapies
-
McIntosh, C. H. S.; Demuth, H.-U.; Kim, S.-J.; Pospisilik, J. A.; Pederson, R. A. Int. J. Biochem. Cell Biol. 2006, 38, 860-872. doi:10.1016/j.biocel.2005.12.013 (Pubitemid 43363417)
-
(2006)
International Journal of Biochemistry and Cell Biology
, vol.38
, Issue.5-6
, pp. 860-872
-
-
McIntosh, C.H.S.1
Demuth, H.-U.2
Kim, S.-J.3
Pospisilik, J.A.4
Pederson, R.A.5
-
4
-
-
0037030602
-
1-[2-[(5-Cyanopyridin-2-yl)amino]-ethylamino]acetyl-2-(S)-pyrrolidine -carbonitrile: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
-
DOI 10.1021/jm025522z
-
Villhauer, E. B.; Brinkman, J. A.; Naderi, G. B.; Dunning, B. E.; Mangold, B. L.; Mone, M. D.; Russel, M. E.; Weldon, S. C.; Hughes, T. E. J. Med. Chem. 2002, 45, 2362-2365. doi:10.1021/jm025522z (Pubitemid 34595207)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.12
, pp. 2362-2365
-
-
Villhauer, E.B.1
Brinkman, J.A.2
Naderi, G.B.3
Dunning, B.E.4
Mangold, B.L.5
Mone, M.D.6
Russell, M.E.7
Weldon, S.C.8
Hughes, T.E.9
-
5
-
-
0036583164
-
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
-
DOI 10.2337/diacare.25.5.869
-
Ahrén, B.; Simonsson, E.; Larson, H.; Landin-Olsson, M.; Torgeirsson, H.; Jansson, P.-A.; Sandqvist, M.; Båvenholm, P.; Efendic, S.; Eriksson, J. W.; Dickinson, S.; Holmes, D. Diabetes Care 2002, 25, 869-875. doi:10.2337/diacare.25.5.869 (Pubitemid 41094285)
-
(2002)
Diabetes Care
, vol.25
, Issue.5
, pp. 869-875
-
-
Ahren, B.1
Simonsson, E.2
Larsson, H.3
Landin-Olsson, M.4
Torgeirsson, H.5
Jansson, P.-A.6
Sandqvist, M.7
Bavenholm, P.8
Efendic, S.9
Eriksson, J.W.10
Dickinson, S.11
Holmes, D.12
-
6
-
-
0037777695
-
1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: A potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties
-
DOI 10.1021/jm030091l
-
Villhauer, E. B.; Brinkman, J. A.; Naderi, G. B.; Burkey, B. F.; Dunning, B. E.; Prasad, K.; Mangold, B. L.; Russel, M. E.; Hughes, T. E. J. Med. Chem. 2003, 46, 2774-2789. doi:10.1021/jm030091l (Pubitemid 36702545)
-
(2003)
Journal of Medicinal Chemistry
, vol.46
, Issue.13
, pp. 2774-2789
-
-
Villhauer, E.B.1
Brinkman, J.A.2
Naderi, G.B.3
Burkey, B.F.4
Dunning, B.E.5
Prasad, K.6
Mangold, B.L.7
Russell, M.E.8
Hughes, T.E.9
-
7
-
-
27744540889
-
Improved glycaemic control with dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes: Vildagliptin (LAF237) dose response
-
DOI 10.1111/j.1463-1326.2005.00539.x
-
Ristic, S.; Byiers, S.; Foley, J.; Holmes, D. Diabetes Obes. Metab. 2005, 7, 692-698. doi:10.1111/j.1463-1326.2005.00539.x (Pubitemid 41601073)
-
(2005)
Diabetes, Obesity and Metabolism
, vol.7
, Issue.6
, pp. 692-698
-
-
Ristic, S.1
Byiers, S.2
Foley, J.3
Holmes, D.4
-
8
-
-
9444285818
-
Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes
-
DOI 10.2337/diacare.27.12.2874
-
Ahrén, B.; Gomis, R.; Standl, E.; Mills, D.; Schweizer, A. Diabetes Care 2004, 27, 2874-2880. doi:10.2337/diacare.27.12.2874 (Pubitemid 39565052)
-
(2004)
Diabetes Care
, vol.27
, Issue.12
, pp. 2874-2880
-
-
Ahren, B.1
Gomis, R.2
Standl, E.3
Mills, D.4
Schweizer, A.5
-
9
-
-
19944427998
-
(2R)-4-Oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A] pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
DOI 10.1021/jm0493156
-
Kim, D.; Wang, L.; Beconi, M.; Eiermann, G. J.; Fisher, M. H.; He, H.; Hickey, G. J.; Kowalchick, J. E.; Leiting, B.; Lyons, K.; Marsilio, F.; McCann, M. E.; Patel, R. A.; Petrov, A.; Scapin, G.; Patel, S. B.; Roy, R. S.; Wu, J. K.; Wyvratt, M. J.; Zhang, B. B.; Zhu, L.; Thornberry, N. A.; Weber, A. E. J. Med. Chem. 2005, 48, 141-151. doi:10.1021/jm0493156 (Pubitemid 40105255)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.1
, pp. 141-151
-
-
Kim, D.1
Wang, L.2
Beconi, M.3
Eiermann, G.J.4
Fisher, M.H.5
He, H.6
Hickey, G.J.7
Kowalchick, J.E.8
Leiting, B.9
Lyons, K.10
Marsilio, F.11
McCann, M.E.12
Patel, R.A.13
Petrov, A.14
Scapin, G.15
Patel, S.B.16
Roy, R.S.17
Wu, J.K.18
Wyvratt, M.J.19
Zhang, B.B.20
Zhu, L.21
Thornberry, N.A.22
Weber, A.E.23
more..
-
10
-
-
32844473903
-
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers
-
DOI 10.1016/j.clinthera.2006.01.015, PII S0149291806000294
-
Bergman, A. J.; Stevens, C.; Zhou, Y.; Yi, B.; Laethem, M.; De Smet, M.; Snyder, K.; Hilliard, D.; Tanaka, W.; Zeng, W.; Tanen, M.; Wang, A. Q.; Chen, L.; Winchell, G.; Davies, M. J.; Ramael, S.; Wagner, J. A.; Herman, G. A. Clin. Ther. 2006, 28, 55-72. doi:10.1016/j.clinthera.2006.01.015 (Pubitemid 43254990)
-
(2006)
Clinical Therapeutics
, vol.28
, Issue.1
, pp. 55-72
-
-
Bergman, A.J.1
Stevens, C.2
Zhou, Y.3
Yi, B.4
Laethem, M.5
De Smet, M.6
Snyder, K.7
Hilliard, D.8
Tanaka, W.9
Zeng, W.10
Tanen, M.11
Wang, A.Q.12
Chen, L.13
Winchell, G.14
Davies, M.J.15
Ramael, S.16
Wagner, J.A.17
Herman, G.A.18
-
12
-
-
22744449063
-
Discovery and preclinical profile of saxagliptin (BMS-477118): A highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
-
DOI 10.1021/jm050261p
-
Augeri, D. J.; Robl, J. A.; Betebenner, D. A.; Magnin, D. R.; Khanna, A.; Robertson, J. G.; Wang, A.; Simpkins, L. M.; Taunk, P.; Huang, Q.; Han, S.-P.; Abboa-Offei, B.; Cap, M.; Xin, L.; Tao, L.; Tozzo, E.; Welzel, G. E.; Egan, D. M.; Marcinkeviciene, J.; Chang, S. Y.; Biller, S. A.; Kirby, M. S.; Parker, R. A.; Hamann, L. G. J. Med. Chem. 2005, 48, 5025-5037. doi:10.1021/jm050261p (Pubitemid 41033142)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.15
, pp. 5025-5037
-
-
Augeri, D.J.1
Robl, J.A.2
Betebenner, D.A.3
Magnin, D.R.4
Khanna, A.5
Robertson, J.G.6
Wang, A.7
Simpkins, L.M.8
Taunk, P.9
Huang, Q.10
Han, S.-P.11
Abboa-Offei, B.12
Cap, M.13
Xin, L.14
Tao, L.15
Tozzo, E.16
Welzel, G.E.17
Egan, D.M.18
Marcinkeviciene, J.19
Chang, S.Y.20
Biller, S.A.21
Kirby, M.S.22
Parker, R.A.23
Hamann, L.G.24
more..
-
13
-
-
0023104829
-
Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut
-
DOI 10.1016/0014-5793(87)81430-8
-
Holst, J. J.; Ørskov, C.; Nielsen, O. V.; Schwartz, T. W. FEBS Lett. 1987, 211, 169-174. doi:10.1016/0014-5793(87)81430-8 (Pubitemid 17049446)
-
(1987)
FEBS Letters
, vol.211
, Issue.2
, pp. 169-174
-
-
Holst, J.J.1
Orskov, C.2
Nielsen, O.V.3
Schwartz, T.W.4
-
14
-
-
0027215348
-
-
doi:10.1111/j.1432-1033.1993.tb17986.x
-
Mentlein, R.; Gallwitz, B.; Schmidt, W. E. Eur. J. Biochem. 1993, 214, 829-835. doi:10.1111/j.1432-1033.1993.tb17986.x
-
(1993)
Eur. J. Biochem.
, vol.214
, pp. 829-835
-
-
Mentlein, R.1
Gallwitz, B.2
Schmidt, W.E.3
-
15
-
-
0029118049
-
-
doi:10.1210/en.136.8.3585
-
Kieffer, T. J.; McIntosh, C. H.; Pederson, R. A. Endocrinology 1995, 136, 3585-3596. doi:10.1210/en.136.8.3585
-
(1995)
Endocrinology
, vol.136
, pp. 3585-3596
-
-
Kieffer, T.J.1
McIntosh, C.H.2
Pederson, R.A.3
-
16
-
-
84876116521
-
Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-IV inhibitors
-
PCT Int. Appl. WO 2007/029086 A2, March 15 2007
-
Sattigeri, J. A.; Andappan, M. M. S.; Kishore, K.; Sethi, S.; Kandalkar, S. R.; Pal, C. K.; Mahajan, D. C.; Ahmed, S.; Parkale, S. S.; Srinivasan, T.; Sharma, L.; Bansal, V. S.; Chugh, A.; Davis, J. A. Derivatives of 3-azabicyclo[3.1.0]hexane as dipeptidyl peptidase-IV inhibitors. PCT Int. Appl. WO 2007/029086 A2, March 15, 2007. Chem. Abstr. 2007, 146, 337727.
-
(2007)
Chem. Abstr.
, vol.146
, pp. 337727
-
-
Sattigeri, J.A.1
Andappan, M.M.S.2
Kishore, K.3
Sethi, S.4
Kandalkar, S.R.5
Pal, C.K.6
Mahajan, D.C.7
Ahmed, S.8
Parkale, S.S.9
Srinivasan, T.10
Sharma, L.11
Bansal, V.S.12
Chugh, A.13
Davis, J.A.14
-
17
-
-
84876129181
-
New adamantane derivatives as dipeptidyl peptidase IV inhibitors, processes for their preparation and pharmaceutical compositions containing them
-
PCT Int. Appl. WO 2006/090244 A1, August 31 2006
-
Gopalan, B.; Thomas, A.; Shah, D. M. New adamantane derivatives as dipeptidyl peptidase IV inhibitors, processes for their preparation and pharmaceutical compositions containing them. PCT Int. Appl. WO 2006/090244 A1, August 31, 2006. Chem. Abstr. 2006, 145, 292604.
-
(2006)
Chem. Abstr.
, vol.145
, pp. 292604
-
-
Gopalan, B.1
Thomas, A.2
Shah, D.M.3
-
18
-
-
84876127560
-
Peptidase inhibitors
-
PCT Int. Appl. WO 2006/012441 A1, February 2 2006
-
Royalty, S. M.; Burns, J. M.; Scicinski, J. J.; Foglesong, R. J.; Jagdmann, G. E., Jr.; Griffin, K. R.; Dyakonov, T.; Middlemiss, D. Peptidase inhibitors. PCT Int. Appl. WO 2006/012441 A1, February 2, 2006. Chem. Abstr. 2006, 144, 192098.
-
(2006)
Chem. Abstr.
, vol.144
, pp. 192098
-
-
Royalty, S.M.1
Burns, J.M.2
Scicinski, J.J.3
Foglesong, R.J.4
Jagdmann Jr., G.E.5
Griffin, K.R.6
Dyakonov, T.7
Middlemiss, D.8
-
19
-
-
84876141532
-
Novel dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
-
PCT Int. Appl. WO 2005/075426 A1, August 18 2005
-
Thomas, A.; Gopalan, B.; Lingam, V. S. P. R.; Shah, D. M. Novel dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof. PCT Int. Appl. WO 2005/075426 A1, August 18, 2005. Chem. Abstr. 2005, 143, 230193.
-
(2005)
Chem. Abstr.
, vol.143
, pp. 230193
-
-
Thomas, A.1
Gopalan, B.2
Lingam, V.S.P.R.3
Shah, D.M.4
-
20
-
-
84876109961
-
Novel dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
-
PCT Int. Appl. WO 2005/033099, April 14 2005
-
Gopalan, B.; Joshi, H. V.; Shah, D. M.; Ghorpade, S. R. Novel dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof. PCT Int. Appl. WO 2005/033099, April 14, 2005. Chem. Abstr. 2005, 142, 392283.
-
(2005)
Chem. Abstr.
, vol.142
, pp. 392283
-
-
Gopalan, B.1
Joshi, H.V.2
Shah, D.M.3
Ghorpade, S.R.4
-
21
-
-
9144220132
-
N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors
-
PCT Int. Appl. WO 03/037327 A1, May 8 2003
-
Boehringer, M.; Hunziker, D.; Kuehne, H.; Loeffler, B. M.; Sarabu, R.; Wessel, H. P. N-substituted pyrrolidin derivatives as dipeptidyl peptidase IV inhibitors. PCT Int. Appl. WO 03/037327 A1, May 8, 2003. Chem. Abstr. 2003, 138, 368754.
-
(2003)
Chem. Abstr.
, vol.138
, pp. 368754
-
-
Boehringer, M.1
Hunziker, D.2
Kuehne, H.3
Loeffler, B.M.4
Sarabu, R.5
Wessel, H.P.6
-
22
-
-
84876142384
-
2-Cyanopyrrolidine derivatives and their use as medicaments
-
PCT Int. Appl. WO 01/96295 A3, December 20 2001
-
Villhauer, E. B. 2-Cyanopyrrolidine derivatives and their use as medicaments. PCT Int. Appl. WO 01/96295 A3, December 20, 2001. Chem. Abstr. 2001, 136, 37503.
-
(2001)
Chem. Abstr.
, vol.136
, pp. 37503
-
-
Villhauer, E.B.1
-
23
-
-
84876107713
-
Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis
-
Eur. Pat. Appl. EP 1598350 A1, November 23 2005
-
De Nanteuil, G.; Benoist, A.; Combettes, M.; Harley, E. Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis. Eur. Pat. Appl. EP 1598350 A1, November 23, 2005. Chem. Abstr. 2005, 143, 477960.
-
(2005)
Chem. Abstr.
, vol.143
, pp. 477960
-
-
De Nanteuil, G.1
Benoist, A.2
Combettes, M.3
Harley, E.4
-
24
-
-
7444256528
-
Synthesis and structure-activity relationships of potent 3- or 4-substituted-2-cyanopyrrolidine dipeptidyl peptidase IV inhibitors
-
DOI 10.1016/j.bmc.2004.09.010, PII S096808960400690X
-
Fukushima, H.; Hiratate, A.; Takahashi, M.; Saito, M.; Munetomo, E.; Kitano, K.; Saito, H.; Takaoka, Y.; Yamamoto, K. Bioorg. Med. Chem. 2004, 12, 6053-6061. doi:10.1016/j.bmc.2004.09.010 (Pubitemid 39440446)
-
(2004)
Bioorganic and Medicinal Chemistry
, vol.12
, Issue.23
, pp. 6053-6061
-
-
Fukushima, H.1
Hiratate, A.2
Takahashi, M.3
Saito, M.4
Munetomo, E.5
Kitano, K.6
Saito, H.7
Takaoka, Y.8
Yamamoto, K.9
-
25
-
-
84876104365
-
-
US Patent Application US 6,271,394 B1, August 7
-
Shekhar, R.; Girgis, M. J. Process for producing amino acid amides. US Patent Application US 6,271,394 B1, August 7, 2001.
-
(2001)
Process for Producing Amino Acid Amides
-
-
Shekhar, R.1
Girgis, M.J.2
-
26
-
-
3543059460
-
Reactions of N-(2-chloroacetyl)-α-amino acids with 3-cyanopyridine-2(1H)-thiones. New promising route to 3,4- dihydropyrido[3,2,4, 5]thieno[3,2-e][1,4]diazepine-2(1H),5-diones
-
DOI 10.1023/B:RUCB.0000011878.52263.c4
-
Fedorov, A. E.; Shestopalov, A. M.; Belyakov, P. A. Russ. Chem. Bull. 2003, 52, 2197-2202. doi:10.1023/B:RUCB.0000011878.52263.c4 (Pubitemid 39030502)
-
(2003)
Russian Chemical Bulletin
, vol.52
, Issue.10
, pp. 2197-2202
-
-
Fedorov, A.E.1
Shestopalov, A.M.2
Belyakov, P.A.3
|